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■ CASE REPORT ■
Introduction
Large cell neuroendocrine carcinoma (LCNEC) of the
uterine cervix is a very rare malignancy that is highly
aggressive and usually results in unfavorable outcomes.
It is considerably less common than the well-recognized
small-cell neuroendocrine carcinoma of the cervix. We
recently encountered a case of LCNEC of the cervix
with coexisting adenocarcinoma of the cervix.
Case Report
A 45-year-old woman, gravida 2, para 0, presented
with intermenstrual bleeding for 7 months. Her history
was significant because of a mildly abnormal Pap
smear, ASCUS, 3 years prior to this consultation. Pelvic
examination revealed a 3-cm polypoid lesion protrud-
ing from the cervical os that was clinically confined 
to the cervix. The vagina was grossly normal and 
the bilateral parametria were free. The exophytic cervi-
cal mass was friable and bled easily on contact. A 
colposcopy-directed biopsy of the cervical lesion re-
vealed a tumor with a trabecular pattern and promi-
nent geographic necrosis. The tumor cells possessed a
moderate amount of cytoplasm, with prominent nucle-
oli and large nuclei (Figure 1). There was a myriad of
apoptotic cells and more than 10 mitoses per 10 high-
power fields (HPF). The tumor cells stained positive
for synaptophysin, chromogranin A, and neuron-
specific enolase (NSE). Histology was consistent with
the diagnosis of LCNEC of the cervix. Serum SCC was
1.0 ng/mL while CEA was 1.7 ng/mL. She also tested
positive for high-risk HPV 18. A computed tomogra-
phy (CT) scan of the pelvis showed an enlarged uterine
cervix with no identifiable enlarged lymph node in 
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the abdominal or pelvic cavity. The patient underwent
a radical hysterectomy, pelvic and paraarotic lymph
node dissection, and transposition of bilateral ovaries
(Class III radical hysterectomy). Bilateral salpingo-
oohorectomy was recommended before surgery; how-
ever, the patient insisted on preserving her ovaries.
Peritoneal washings were also taken for cytologic
examination.
The uterus in the radical hysterectomy specimen
grossly showed multiple myomas, adenomyosis, and a
3.0 × 1.09 × 0.6 cm tumor mass located at the uterine
cervix (Figure 2). Pathologic examination of the cervix
demonstrated LCNEC invading the inner 6 mm of the
cervical wall. The parametrium, uterus, vagina, 39 lymph
nodes, and peritoneal washings were free of cancer.
Multiple foci of the adenocarcinoma were also noted
on the cervix (Figure 3).
The patient later received postoperative radia-
tion therapy of the pelvis (33 cGy in 24 fractions),
reduced pelvis (5cGy in 4 fractions), and intravaginal
brachytherapy (15cGy in 7 fractions) with concomi-
tant weekly chemotherapy with cisplatin 40 mg/m2 (six
cycles), followed by three cycles of monthly chemother-
apy with cisplatin 50 mg/m2. Therapy was well tolerated
and no relapse has been observed for 2 years.
Discussion
Endocrine carcinomas are rare, accounting for nearly 5%
of all cervical carcinomas. Neuroendocrine carcinomas
of the uterine cervix, particularly those comprising large
cells are even more uncommon, with fewer than 50 cases
documented in the English literature [1–5]. Clinically,
patients are younger with median age of 42 years [6].
A new classification system for neuroendocrine
tumors of the cervix has been proposed by the College
of American Pathologists namely: large cell, small cell,
classical carcinoid, and atypical carcinoid [7]. The small
cell endocrine tumors have small round cells with mini-
mal cytoplasm, abundant mitotic figures, and extensive
necrosis. The classical carcinoid has no cytologic atypia,
no necrosis, and rare mitotic figures. Atypical carcinoid
on the other hand possesses cytologic atypia, ≤ 10
mitotic figures/HPF and focal necrosis. Histologic 
criteria for diagnosis of cervical LCNEC include the pres-
ence of large cells with vesicular nuclei and prominent
nucleoli, a mitotic index in excess of 10/10 HPFs, and
geographical areas of tumor necrosis. Other features
of these tumors include the presence of neurosecretory
granules with an inconspicuous amount (< 5%) of
glandular or squamous component. Tumors are argy-
rophylic (a neuroendocrine marker) and stain immuno-
histochemically with synaptophysin, chromogranin, and
NSE [8].
Taiwanese J Obstet Gynecol • March 2007 • Vol 46 • No 1 69
Neuroendocrine Large Cell Carcinoma of the Cervix
Figure 1. Histology of the cervical lesion with tumor cells
possessing abundant cytoplasm, prominent nucleoli and large
nuclei (hematoxylin and eosin, 400×).
Figure 3. Histology of the well-differentiated invasive adeno-
carcinoma of the cervix. Note the cribriform structure in the
tumor glands and desmoplastic change over the stroma
(hematoxylin and eosin, 400×).
Figure 2. Cervix with the polypoid mass localized at the uterine
cervix.
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Accurate diagnosis of cervical LCNEC is of prognos-
tic importance. Gilks et al [2] identified 65% mortality
rate within 3 years of diagnosis. Moreover, in their
study of 21 stage I cervical LCNEC cases, 12 patients
died of the disease after a median survival period of 
16 months.
It has been suggested that viral exposure, host, and
other nonviral factors may play roles in the pathogene-
sis of cervical cancer. According to Grayson et al [9],
the integration of high-risk type HPV, in particular,
type 16 and to a lesser degree type 18, was associated
with LCNEC of the uterine cervix.
In this case, LCNEC of the cervix was noted to
coexist with adenocarcinoma. As evident in Figure 3,
adenocarcinoma with neuroendocrine differentiation
was possible due to the presence of glandular struc-
tures along with the well-differentiated invasive adeno-
carcinoma. Such an entity has been described in other
reports in the literature as divergent differentiation
rather than synchronous carcinomas. Since neuroen-
docrine differentiation is common in invasive glandular
lesions of the cervix, such as adenocarcinoma, neu-
roendocrine carcinomas have been postulated to arise
from cervical glandular reserve cells as well as from cervi-
cal endocrine cells [6,10,11]. Hence, adenocarcinoma
having both well- and poorly differentiated components,
with the latter component showing that neuroendocrine
differentiation is plausible.
The treatment of LCNEC of the cervix remains contro-
versial due to the rarity of the disease. In our institution,
three cycles of adjuvant chemotherapy and concurrent
radiation is offered to patients with paraarotic lymph
nodes positive for adenocarcinoma. However, we do not
have solid evidence to support or oppose this treatment
regimen. Further study is warranted.
Aggressive initial multimodality treatment with radi-
cal hysterectomy and adjuvant chemoradiation is 
recommended [2,7].
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